I am aware of patient need for this.
FDA Approves Sublingual Ragweed Allergy Treatment — Physician’s First Watch
FDA Approves Sublingual Ragweed Allergy Treatment
By the Editors
The FDA has approved Ragwitek to treat hay fever, with and without conjunctivitis, caused by short ragweed pollen. The pill, to be taken sublingually, contains an extract of short ragweed pollen.
Adults should take Ragwitek daily for 12 weeks before ragweed pollen season begins and should continue to do so during the season. It will contain a boxed warning alerting patients of the potential for severe allergic reactions.